Financhill
Back

EyePoint Pharmaceuticals Vs. BNP Paribas Industry Stock Comparison

Sell
40

EYPT
EyePoint Pharmaceuticals

Last Price:
$6.64
Seasonality Move:
-1.71%
Buy
55

BNPQF
BNP Paribas

Last Price:
$86.65
Seasonality Move:
1.34%
Sell
40
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $6.78. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
BNP Paribas (BNPQF) is a Buy

Is BNP Paribas a Buy, Sell or Hold?

  • The current BNP Paribas [BNPQF] share price is $84.54. The Score for BNPQF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • BNPQF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $6.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BNPQF Stock Price Chart

What is BNP Paribas's stock price today?

  • The BNP Paribas share price today is $84.54
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNPQF is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 62.18 Buy
Chaikin Money Flow: 417062 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.91 - 6.35) Buy
Bollinger Bands (100): (5.76 - 8.02) Sell

BNPQF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.95 Buy
Relative Strength Index (14 RSI): 57.96 Buy
Chaikin Money Flow: -2791 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.17 - 85.01) Buy
Bollinger Bands (100): (62.4 - 80.84) Buy

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.25 Buy
20-day SMA: 5.52 Buy
50-day SMA: 6.04 Buy
200-day SMA: 8.11 Sell
8-day EMA: 6.28 Buy
20-day EMA: 5.94 Buy
50-day EMA: 6.18 Buy
200-day EMA: 8.38 Sell

BNPQF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.79 Buy
20-day SMA: 79.35 Buy
50-day SMA: 79.75 Buy
200-day SMA: 69.63 Buy
8-day EMA: 82.08 Buy
20-day EMA: 80.68 Buy
50-day EMA: 78.38 Buy
200-day EMA: 71.44 Buy

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

BNP Paribas Earnings Growth & BNPQF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BNP Paribas Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):